Vol 19, No 6 (2012)
Review Article
Published online: 2012-12-06

open access

Page views 1260
Article views/downloads 1975
Get Citation

Connect on Social Media

Connect on Social Media

Management of arrhythmias in heart failure. What a practicing physician should know in the current times

Rajesh Ramineni, Mani Kumar Bheemarasetti, Adrian Baranchuk, Tapasya Mandalapu, Venkat K. Mukku, Ken Fujise, Alejandro Barbagelata
DOI: 10.5603/CJ.2012.0107
Cardiol J 2012;19(6):567-577.


Arrhythmias play a significant role in the mortality and morbidity as well as hospitalizations of patients who carry a diagnosis of congestive heart failure. With improving survival in a world of novel medications and devices, an understanding of the pathophysiology and management of these arrhythmias is crucial. Majority of the basic heart failure medications such as beta- -blockers, angiotensin converting enzyme inhibitors/aldosterone receptor blockers and aldosterone antagonists play a pivotal role in prevention of sudden cardiac deaths which can be a direct/indirect result of these arrhythmias. Anti-arrhythmic drugs and implantable cardioverter- -defibrillators were also beneficial in selected patients. Innovative electrophysiological techniques need to be considered in special situations.

Article available in PDF format

View PDF Download PDF file